Semigran Marc - 24 Jan 2022 Form 4 Insider Report for Renovacor, Inc. (RCOR)

Role: Chief Medical Officer
Signature: /s/ Joseph Carroll, as attorney-in-fact
Issuer symbol: RCOR
Transactions as of: 24 Jan 2022
Transactions value $: $0
Form type: 4
Filing time: 26 Jan 2022, 17:30:32 UTC
Previous filing: 22 Dec 2021
Next filing: 05 Dec 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	RCOR	Common Stock	Award	$0	+17.4K	+49.47%	$0.00	52.7K	24 Jan 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	RCOR	Stock Option	Award	$0	+34.9K		$0.00	34.9K	24 Jan 2022	Common Stock	34.9K	$6.45	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These restricted stock units will vest in four equal annual installments beginning on January 24, 2023, subject to continued service with the Company.
F2	The stock option will vest and become exercisable in full on January 24, 2026, with 25% vesting on January 24, 2023, and the remainder vesting in equal monthly installments on the24th of each month for the remaining 36months, subject to the continuous service of the Reporting Person on such vesting date.